AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.

These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes. 

  • VASCULAR INTERVENTIONS & THERAPIES
  • VASCULAR ACCESS
  • ONCOLOGY

Changing Lives

Each day, AngioDynamics and its employees earn the trust of patients and the medical community by being a committed partner that continuously focuses on delivering safer, clinically-relevant and economically-favorable solutions that help improve patient outcomes.

Patients Are The Focus
Warren's Story

Being innovative is one thing, being part of a patient's...continuum of care, that's something that makes me get up every day and it's a powerful feeling.


Our Culture is Our Success

Become a proud member of our team

It takes a team of talented people to become one of the world’s leading providers of innovative medical devices. 

The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.

If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.

View Open Positions
06 Feb, 2020

AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
16 Jan, 2020

AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System

American Urological Association (AUA)

Date: 15 May, 2020
Time:
Location: Washington, DC

07 Jan, 2020

AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results
06 Jan, 2020

AngioDynamics to Present at the J.P. Morgan Healthcare Conference
More News & Events

New Developments

AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has ...

Read More

Our Reach is Global

AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.

Offices in:

USA

  • Latham, NY (HQ)
  • Glens Falls, NY (Manufacturing)
  • Queensbury, NY (Manufacturing)
  • Marlborough, MA (R&D)

International

  • Amsterdam, NL
    (International HQ)
  • São Paulo, BR
    (Brazil Office)
  • Oakville, CA
    (Canada Office)
  • Hong Kong, HK
    (Asia Pacific Regional Office)